z-logo
open-access-imgOpen Access
A patient who does not like insulin
Author(s) -
P. Ubaldi
Publication year - 2018
Publication title -
aboutopen
Language(s) - English
Resource type - Journals
ISSN - 2465-2628
DOI - 10.19156/abtpn.2018.0057
Subject(s) - diabetology , medicine , safer , disease , diabetes mellitus , insulin , population , intensive care medicine , surgery , general surgery , pediatrics , endocrinology , computer security , environmental health , computer science
Hypoglycemic therapy over the past 20 years has expanded considerably with the use of new classes of more effective and safer medicines. Alongside the aging of the general population, the survival of diabetic subjects has significantly increased, thus exposing them to a greater risk of developing co-morbidities. This represents a challenge for the diabetologist, who must acquire ever broader concepts for the management of a complex and multi-organ disease. We report the case of a 72-year-old woman with type 2 diabetes mellitus and pulmonary adenocarcinoma of the right upper lobe with brain and bone metastases who, subjected to innovative and integrated treatments agreed between specialists of different disciplines, is still alive and free of cancer symptoms 23 months after diagnosis (Diabetology)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here